Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
COMVIGEN (ChulaCov19 BNA159.2) vaccine (50 mcg)
/
mega-study
COMVIGEN (ChulaCov19 BNA159.2) vaccine (50 mcg)